Boston Partners bought a new stake in shares of Encompass Health Corporation (NYSE:EHC – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,300,859 shares of the company’s stock, valued at approximately $158,053,000.
Other hedge funds have also recently made changes to their positions in the company. Meeder Asset Management Inc. boosted its position in Encompass Health by 5.4% in the 3rd quarter. Meeder Asset Management Inc. now owns 46,041 shares of the company’s stock valued at $5,594,000 after buying an additional 2,372 shares during the period. Composition Wealth LLC grew its stake in Encompass Health by 17.4% in the 3rd quarter. Composition Wealth LLC now owns 5,652 shares of the company’s stock worth $687,000 after acquiring an additional 836 shares in the last quarter. Voya Investment Management LLC increased its position in shares of Encompass Health by 4.7% during the third quarter. Voya Investment Management LLC now owns 10,354 shares of the company’s stock worth $1,258,000 after acquiring an additional 466 shares during the period. Cibc World Market Inc. purchased a new position in shares of Encompass Health during the third quarter worth approximately $202,000. Finally, Virtus Advisers LLC raised its stake in shares of Encompass Health by 16.8% during the third quarter. Virtus Advisers LLC now owns 5,175 shares of the company’s stock valued at $629,000 after acquiring an additional 743 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Encompass Health
In other Encompass Health news, EVP John Darby sold 4,858 shares of the business’s stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $121.09, for a total transaction of $588,255.22. Following the completion of the sale, the executive vice president directly owned 75,041 shares in the company, valued at approximately $9,086,714.69. The trade was a 6.08% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.80% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
A number of analysts recently issued reports on EHC shares. Truist Financial reiterated a “buy” rating and issued a $156.00 price target (up from $150.00) on shares of Encompass Health in a report on Friday, October 30th. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. Raymond James Financial reaffirmed a “strong-buy” rating and set a $155.00 target price on shares of Encompass Health in a research report on Friday, October 30th. Weiss Ratings upgraded Encompass Health from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Finally, Mizuho set a $155.00 target price on Encompass Health in a report on Monday, November 2nd. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $154.25.
View Our Latest Stock Report on Encompass Health
Key Encompass Health News
Investors following EHC have been watching these news items:
- Positive Sentiment: Zacks Research increased estimates for multiple periods, including FY2026 EPS to $6.24, FY2027 to $6.65, and FY2028 to $7.44. It also lifted several quarterly forecasts, including Q2 2028 to $1.94 per share. These upward revisions indicate stronger analyst expectations for earnings growth. Encompass Health analyst estimates
- Neutral Sentiment: A separate Zacks article described EHC as a long-term value-stock candidate, but the provided summary gives no specific valuation data or new company developments to gauge the claim’s immediate impact. Why Encompass Health is a Top Value Stock for the Long-Term
Encompass Health Price Performance
Shares of EHC opened at $132.05 on Friday. The company has a 50 day moving average of $127.94 and a two-hundred day moving average of $112.87. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.73. Encompass Health Corporation has a twelve month low of $92.77 and a twelve month high of $143.90. The company has a market cap of $12.96 billion, a price-to-earnings ratio of 20.63, a price-to-earnings-growth ratio of 2.34 and a beta of 0.83.
Encompass Health (NYSE:EHC – Get Free Report) last released its earnings results on Wednesday, October 28th. The company reported $1.52 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.16. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.60 billion. Encompass Health had a return on equity of 18.35% and a net margin of 10.17%. The company’s revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.23 earnings per share. As a group, analysts predict that Encompass Health Corporation will post 6.28 earnings per share for the current fiscal year.
Encompass Health Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Stockholders of record on Monday, January 4th will be paid a dividend of $0.21 per share. The ex-dividend date of this dividend is Monday, January 4th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.6%. Encompass Health’s payout ratio is currently 13.12%.
About Encompass Health
Encompass Health Corporation is a U.S. healthcare provider focused on inpatient rehabilitation. The company operates rehabilitation hospitals that offer specialized care for people recovering from conditions such as strokes, brain and spinal cord injuries, orthopedic conditions, and other illnesses or injuries. Its hospitals provide coordinated rehabilitation services, including physical, occupational, and speech therapy, alongside medical care. Encompass Health serves patients through facilities across the United States.
Featured Stories
- Five stocks we like better than Encompass Health
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC – Free Report).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
